Glycans in Diseases and Therapeutics


Glycomedicine functions as essential role in cell-cell adhesion i.e. a device used by cells of the immune system through sugar-binding proteins called lectins, which classify precise carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play leading roles in various biological phenomena as well as in numerous pathophysiological procedures. Several scientists have now understood that glycosylation, i.e. the count of glycans to a protein backbone, is the most plentiful post translational alteration responses and is a major field of research and sometimes they require a glycobiology method to be exploited


  • Glycomedicine
  • Transfusion medicine
  • Congenital disorders of glycosylation (CDG)
  • Cancer biomarkers
  • Cardiovascular diseases
  • Cardiac arrest
  • Cancer associated coagulopathies

Related Conference of Glycans in Diseases and Therapeutics

March 07-08, 2024

14th World Glycobiology Congress

Toronto, Canada
March 07-08, 2024

30th Asia Pacific Biotechnology Congress

Dubai, UAE
March 28-29, 2024

6th International Conference on Biochemistry

Dubai, UAE
September 25-26, 2024

20th World Congress on Structural Biology

Paris, France
October 03-04, 2024

15th International Conference on Biofuels and Bioenergy

Singapore City, Singapore
December 12-13, 2024

15th World Congress on Cell & Tissue Science

Rome, Italy

Glycans in Diseases and Therapeutics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in